News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CeNeS Pharmaceuticals PLC (CEN.L) Licenses New Intravenous Anaesthetic to Ono Pharmaceutical Company, Ltd. in Japan


8/10/2007 11:16:01 AM

CeNeS Pharmaceuticals plc (LSE: CEN), the Cambridge based biopharmaceutical company announced today that Ono Pharmaceutical Co., Ltd. (Osaka, Japan, CEO: Toshiharu Korekane) has obtained from CeNeS the exclusive rights in Japan to develop and commercialize CNS-7056 developed by CeNeS as a general anaesthetic and short-acting sedative. Under this agreement, Ono will pay to CeNeS upfront and milestone payments based on development stage as well as royalties on sales of CNS-7056.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES